Kirk Jones, MD

Pathologist

Dr. Kirk Jones is a pathologist in surgical pathology and cytopathology. Pathology is the study of disease and involves examining tissue removed during surgery or biopsy to make diagnoses and guide patient care. Jones has a special expertise in pulmonary, or lung, pathology and is responsible for the examining all tissue biopsies for UCSF's Interstitial Lung Disease Program. He also examines lungs removed during surgery for the lung transplant program, and evaluates all post-transplant lung biopsies for signs of infection or rejection of the transplanted lung. He is the primary pathologist for the Thoracic Interdisciplinary Tumor Board and an assistant professor of pathology at the UCSF School of Medicine.

Jones earned a medical degree at UCSF and did a combined residency here, in anatomic pathology and laboratory medicine. His fellowship in cytopatholgy was also completed at UCSF. After his fellowship, he was a visiting scholar at the Mayo Clinic in Scottsdale, Ariz., where he studied pulmonary pathology with Dr. Thomas V. Colby and Dr. Kevin O. Leslie. He is a member of the United States and Canadian Academy of Pathology, Pulmonary Pathology Society, International Association for the Study of Lung Cancer, College of American Pathologists and South Bay Pathology Society.

Clinics

Fine Needle Aspiration Biopsy Clinic
1825 Fourth St., Fourth Floor
San Francisco, CA 94158
Phone: (415) 353-7043
Fax: (415) 353-7676

Hours: Monday to Friday
9:30 a.m. – 5 p.m.

Fine Needle Aspiration Biopsy Clinic
1600 Divisadero St., Suite 200
San Francisco, CA 94143
Phone: (415) 353-7043
Fax: (415) 353-7676

Hours: Monday to Friday
9:30 a.m. – 5 p.m.

ILD Program
400 Parnassus Ave., Fifth Floor
San Francisco, CA 94143
Phone: (415) 353-2577
Fax: (415) 353-8944

Conditions & Treatments

Academic Title

Professor

More about Kirk Jones

Education

UCSF 1994

Residencies

UCSF, Anatomic Pathology and Laboratory Medicine 1998

Fellowships

UCSF, Surgical pathology and cytopathology 1999

Selected Research and Publications

  1. Jones KD. Unclassifiable interstitial lung disease: a pathologist's perspective. Eur Respir Rev. 2018 Mar 31; 27(147).
  2. Morisset J, Johannson KA, Jones KD, Wolters PJ, Collard HR, Walsh SLF, Ley B. Identification of Diagnostic Criteria for Chronic Hypersensitivity Pneumonitis: An International Modified Delphi Survey. Am J Respir Crit Care Med. 2017 Nov 27.
  3. Ley B, Newton CA, Arnould I, Elicker BM, Henry TS, Vittinghoff E, Golden JA, Jones KD, Batra K, Torrealba J, Garcia CK, Wolters PJ. The MUC5B promoter polymorphism and telomere length in patients with chronic hypersensitivity pneumonitis: an observational cohort-control study. Lancet Respir Med. 2017 Aug; 5(8):639-647.
  4. Morisset J, Vittinghoff E, Elicker BM, Hu X, Le S, Ryu JH, Jones KD, Haemel A, Golden JA, Boin F, Ley B, Wolters PJ, King TE, Collard HR, Lee JS. Mortality Risk Prediction in Scleroderma-Related Interstitial Lung Disease: The SADL Model. Chest. 2017 11; 152(5):999-1007.
  5. Woodard GA, Wang SX, Kratz JR, Zoon-Besselink CT, Chiang CY, Gubens MA, Jahan TM, Blakely CM, Jones KD, Mann MJ, Jablons DM. Adjuvant Chemotherapy Guided by Molecular Profiling and Improved Outcomes in Early Stage, Non-Small-Cell Lung Cancer. Clin Lung Cancer. 2018 Jan; 19(1):58-64.
  6. Morisset J, Vittinghoff E, Lee BY, Tonelli R, Hu X, Elicker BM, Ryu JH, Jones KD, Cerri S, Manfredi A, Sebastiani M, Gross AJ, Ley B, Wolters PJ, King TE, Kim DS, Collard HR, Lee JS. The performance of the GAP model in patients with rheumatoid arthritis associated interstitial lung disease. Respir Med. 2017 Jun; 127:51-56.
  7. Natalini JG, Swigris JJ, Morisset J, Elicker BM, Jones KD, Fischer A, Collard HR, Lee JS. Understanding the determinants of health-related quality of life in rheumatoid arthritis-associated interstitial lung disease. Respir Med. 2017 Jun; 127:1-6.
  8. Wang P, Jones KD, Urisman A, Elicker BM, Urbania T, Johannson KA, Assayag D, Lee J, Wolters PJ, Collard HR, Koth LL. Pathologic Findings and Prognosis in a Large Prospective Cohort of Chronic Hypersensitivity Pneumonitis. Chest. 2017 09; 152(3):502-509.
  9. Brownell R, Moua T, Henry TS, Elicker BM, White D, Vittinghoff E, Jones KD, Urisman A, Aravena C, Johannson KA, Golden JA, King TE, Wolters PJ, Collard HR, Ley B. The use of pretest probability increases the value of high-resolution CT in diagnosing usual interstitial pneumonia. Thorax. 2017 May; 72(5):424-429.
  10. Morisset J, Johannson KA, Vittinghoff E, Aravena C, Elicker BM, Jones KD, Fell CD, Manganas H, Dubé BP, Wolters PJ, Collard HR, Ryerson CJ, Ley B. Use of Mycophenolate Mofetil or Azathioprine for the Management of Chronic Hypersensitivity Pneumonitis. Chest. 2017 03; 151(3):619-625.
  11. Kanegai CM, Xi Y, Donne ML, Gotts JE, Driver IH, Amidzic G, Lechner AJ, Jones KD, Vaughan AE, Chapman HA, Rock JR. Persistent Pathology in Influenza-Infected Mouse Lungs. Am J Respir Cell Mol Biol. 2016 10; 55(4):613-615.
  12. Disayabutr S, Kim EK, Cha SI, Green G, Naikawadi RP, Jones KD, Golden JA, Schroeder A, Matthay MA, Kukreja J, Erle DJ, Collard HR, Wolters PJ. miR-34 miRNAs Regulate Cellular Senescence in Type II Alveolar Epithelial Cells of Patients with Idiopathic Pulmonary Fibrosis. PLoS One. 2016; 11(6):e0158367.
  13. Johannson KA, Elicker BM, Vittinghoff E, Assayag D, de Boer K, Golden JA, Jones KD, King TE, Koth LL, Lee JS, Ley B, Wolters PJ, Collard HR. A diagnostic model for chronic hypersensitivity pneumonitis. Thorax. 2016 10; 71(10):951-4.
  14. Haas BM, Elicker BM, Nguyen J, Ordovas KG, Jones KD, Henry TS, Naeger DM. Nondiagnostic Computed Tomography-guided Percutaneous Lung Biopsies Are More Likely When Infection Is Suspected. J Thorac Imaging. 2016 May; 31(3):151-5.
  15. Jones MG, Walsh SL, Jones KD, Richeldi L. Idiopathic pulmonary fibrosis: securing a confident diagnosis for every patient. Eur Respir J. 2016 Apr; 47(4):1057-9.
  16. Elicker BM, Jones KD, Henry TS, Collard HR. Multidisciplinary Approach to Hypersensitivity Pneumonitis. J Thorac Imaging. 2016 Mar; 31(2):92-103.
  17. Woodard GA, Jones KD, Jablons DM. Lung Cancer Staging and Prognosis. Cancer Treat Res. 2016; 170:47-75.
  18. Assayag D, Kim EJ, Elicker BM, Jones KD, Golden JA, King TE, Koth LL, Shum AK, Wolters PJ, Collard HR, Lee JS. Survival in interstitial pneumonia with features of autoimmune disease: a comparison of proposed criteria. Respir Med. 2015 Oct; 109(10):1326-31.
  19. Hindi SM, Wang Y, Jones KD, Nussbaum JC, Chang Y, Masharani U, Bikle D, Shoback DM, Hsiao EC. A Case of Hypercalcemia and Overexpression of CYP27B1 in Skeletal Muscle Lesions in a Patient with HIV Infection After Cosmetic Injections with Polymethylmethacrylate (PMMA) for Wasting. Calcif Tissue Int. 2015 Dec; 97(6):634-9.
  20. Assayag D, Vittinghoff E, Ryerson CJ, Cocconcelli E, Tonelli R, Hu X, Elicker BM, Golden JA, Jones KD, King TE, Koth LL, Lee JS, Ley B, Shum AK, Wolters PJ, Ryu JH, Collard HR. The effect of bronchodilators on forced vital capacity measurement in patients with idiopathic pulmonary fibrosis. Respir Med. 2015 Aug; 109(8):1058-62.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.